Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Short term Debt (2023 - 2025)

Cannabis Bioscience International Holdings' Short term Debt history spans 3 years, with the latest figure at $14592.0 for Q4 2025.

  • For Q4 2025, Short term Debt changed 0.0% year-over-year to $14592.0; the TTM value through Nov 2025 reached $14592.0, changed 0.0%, while the annual FY2025 figure was $14592.0, N/A changed from the prior year.
  • Short term Debt for Q4 2025 was $14592.0 at Cannabis Bioscience International Holdings, roughly flat from $14592.0 in the prior quarter.
  • Across five years, Short term Debt topped out at $73228.0 in Q1 2025 and bottomed at $7054.0 in Q1 2024.
  • The 3-year median for Short term Debt is $14592.0 (2023), against an average of $19152.8.
  • The largest YoY upside for Short term Debt was 938.11% in 2025 against a maximum downside of 0.0% in 2025.
  • A 3-year view of Short term Debt shows it stood at $12079.0 in 2023, then rose by 20.8% to $14592.0 in 2024, then changed by 0.0% to $14592.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Short term Debt are $14592.0 (Q4 2025), $14592.0 (Q3 2025), and $14592.0 (Q2 2025).